Abstract

Metabolomic analysis is an emerging new diagnostic tool, which holds great potential for improving the understanding of osteoarthritis (OA)-caused metabolomic shifts associated with systemic inflammation and oxidative stress. The main aim of the study was to map the changes of amino acid, biogenic amine and complex lipid profiles in severe OA, where the shifts should be more eminent compared with early stages. The fasting serum of 70 knee and hip OA patients and 82 controls was assessed via a targeted approach using the AbsoluteIDQ™ p180 kit. Changes in the serum levels of amino acids, sphingomyelins, phoshatidylcholines and lysophosphatidylcholines of the OA patients compared with controls suggest systemic inflammation in severe OA patients. Furthermore, the decreased spermine to spermidine ratio indicates excessive oxidative stress to be associated with OA. Serum arginine level was positively correlated with radiographic severity of OA, potentially linking inflammation through NO synthesis to OA. Further, the level of glycine was negatively associated with the severity of OA, which might refer to glycine deficiency in severe OA. The current study demonstrates significant changes in the amino acid, biogenic amine and low-molecular weight lipid profiles of severe OA and provides new insights into the complex interplay between chronic inflammation, oxidative stress and OA.

Highlights

  • Osteoarthritis (OA) is considered the most prevalent joint disease and among the leading causes of disability in the elderly population

  • The main aim of the study was to map the systemic changes of amino acids, biogenic amines and complex lipid profiles in end-stage OA compared with controls and identify potential systemic serum biomarkers that could be used in clinical practice

  • There were no significant differences in age, gender proportions, total cholesterol, low-density lipoprotein (LDL) cholesterol and fasting glucose levels between the study groups

Read more

Summary

Introduction

Osteoarthritis (OA) is considered the most prevalent joint disease and among the leading causes of disability in the elderly population. Even though OA has previously been considered as non-inflammatory local “wear and tear” damage of the joint, the understanding has changed and the role of systemic processes of the disease (low-grade inflammation, elevated oxidative stress) has been recognized. Metabolites 2020, 10, 323 we are still currently lacking a disease-modifying therapy. One of the possible tools that could further our understanding of the disease is metabolomics. Metabolomics is a new and emerging approach that investigates a considerable number of small metabolites that are the intermediates and end-products of many cellular processes.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.